|
KR20210010365A
|
|
Fusion tag for preparing protein or polypeptide
|
|
KR20210010366A
|
|
Fusion tag for preparing glucagon-like peptide-1 or analogues
|
|
KR20210010368A
|
|
Fusion tag for preparing glucagon-like peptide-2 or analogues
|
|
KR20210010367A
|
|
Fusion tag for preparing human parathyroid hormone 1-34
|
|
KR20190098689A
|
|
Method of preparing glucagon like peptide-1 or analogues using fusion polypeptide
|
|
KR102009709B1
|
|
Method of preparing human parathyroid hormone 1-84 using fusion polypeptide
|
|
EP3741774A1
|
|
N-terminal fusion partner for producing recombinant polypeptide, and method for producing recombinant polypeptide using same
|
|
KR20190098690A
|
|
Method of preparing glucagon like peptide-2 or analogues using fusion polypeptide
|
|
KR20190088916A
|
|
N-terminal fusion partner for preparing recombinant polypeptide and method of preparing recombinant polypeptide using the same
|
|
KR102011291B1
|
|
Novel fusion polypeptide and method of preparing human parathyroid hormone 1-34 using the same
|
|
KR20200018088A
|
|
Compositions to delay, prevent, alleviate, reverse or treat senenscence-associated diseases and/or disabilities
|
|
KR20190108232A
|
|
Method for detecting molecular target interactions by conditional and controlled exposure or release of molecules
|
